Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcεRI signalling

被引:0
作者
Tomoya Nakamura
Naoki Yoshida
Yu Yamanoi
Akira Honryo
Hiroyuki Tomita
Hiroki Kuwabara
Yoshihiko Kojima
机构
[1] Ikeda Mohando Co.,Department of R&D Center
[2] Ltd,undefined
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Eucalyptus oil has been used since ancient times for its bactericidal, anti-inflammatory, analgesic and sedative effects. In recent years, the action of Eucalyptus oil has been scientifically proven, and there have been reports that Eucalyptus oil suppresses the production of chemokines, cytokines and lipid mediators in basophils, alveolar macrophages and monocytes. Based on this information, we aimed to verify whether Eucalyptus oil can be used for allergic dermatitis, the incidence of which has been increasing among human skin diseases. This effect was verified using a mouse IgE-mediated local allergic model. In conclusion, topical application of Eucalyptus oil suppressed oedema and vascular permeability enhancement due to IgE-mediated allergic on the skin. In addition, we also verified the degranuration of mast cells, which is a part of its action, and examined whether 1,8-cineole, which is the main component of Eucalyptus oil, suppresses the phosphorylation of PLCγ and p38 directly or indirectly. 1,8-cineole was found to suppress degranulation of mast cells.
引用
收藏
相关论文
共 102 条
  • [1] Hart PH(2000)Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes Inflamm. Res. 49 619-626
  • [2] Byard R(1988)Traditional medicine of aboriginal Australia CMAJ 139 792-794
  • [3] Akhtar MA(2016)Medicinal plants of the australian aboriginal Dharawal people exhibiting anti-inflammatory activity Evid. Based Complement. Alternat. Med. 2016 2935403-742
  • [4] Raju R(2009)Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial Respir. Res. 10 69-256
  • [5] Beattie KD(2004)Therapy for acute nonpurulent rhinosinusitis with cineole: Results of a double-blind, randomized, placebo-controlled trial Laryngoscope 114 738-358
  • [6] Bodkin F(2003)Anti-inflammatory activity of 18-cineol (eucalyptol) in bronchial asthma: A double-blind placebo-controlled trial Respir Med. 97 250-256
  • [7] Munch G(1999)Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators Arzneimittelforschung 49 351-646
  • [8] Worth H(2001)Screening of several Indonesian medicinal plants for their inhibitory effect on histamine release from RBL-2H3 cells J. Ethnopharmacol. 75 249-572
  • [9] Schacher C(2014)Anti-inflammatory properties of the monoterpene 1.8-cineole: Current evidence for co-medication in inflammatory airway diseases Drug Res. (Stuttg) 64 638-1074
  • [10] Dethlefsen U(2014)1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice Inflammation 37 566-209